Potential Effects of Novel Sensorimotor Upper Limb Rehabilitation Paradigm
Potential Effects of a Robot-based Upper Limb Rehabilitation Paradigm in Different Subgroups After Stroke: a Pilot Study
2 other identifiers
interventional
10
1 country
1
Brief Summary
Sensorimotor function of the upper limb is often impaired after stroke, even in the chronic phase (minimum 6 months after stroke). Currently, an optimal intervention combining both motor and sensory function, with focus on sensory processing (one of the most important sensory functions), does not exists. However, the research team has developed a novel therapy paradigm combining robot-based training, a transfer package to daily life activities, and a home program. As a first step, the investigators will examine the feasibility and potential benefits of this novel therapy approach within this pilot study by recruiting 10 persons with chronic stroke. The investigators hypothesize that this therapy approach is feasible and potentially effective in chronic stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Feb 2025
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 18, 2025
CompletedFirst Submitted
Initial submission to the registry
March 6, 2025
CompletedFirst Posted
Study publicly available on registry
March 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 2, 2025
CompletedMarch 19, 2026
March 1, 2026
8 months
March 6, 2025
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Action Research Arm Test
Clinical assessment of motor activity performance on an ordinal scale ranging from 0 to 57, with higher scores meaning better performance
From first measuring moment to last measuring moment after 8 weeks.
Secondary Outcomes (9)
Sensorimotor Action Research Arm Test
From first measuring moment to last measuring moment after 8 weeks.
Fugl-Meyer upper extremity assessment
From first measuring moment to last measuring moment after 8 weeks.
Tactile discrimination test
From first measuring moment to last measuring moment after 8 weeks.
Stroke Impact Scale
From first measuring moment to last measuring moment after 8 weeks.
Kinarm: Visually guided reaching task
From first measuring moment to last measuring moment after 8 weeks.
- +4 more secondary outcomes
Study Arms (1)
ROBUST intervention
EXPERIMENTALThe participants will be measured a first time with both robot-based and clinical assessments. Thereafter, the participant follows a 4-week control period, only receiving standard care. After the control period, a second measuring moment is planned using the same outcome measures as during the first measurement. Then, a the 4-week intervention is planned, whereby participants get 48 hours additional sensorimotor upper limb training. They will come 3 times per week to Leuven for a therapy session of two hours. During these therapy sessions, they receive one hour robot-based therapy and one hour transfer package training with a therapist. Additionally, they follow 6 times a week a 1-hour home program. After this intervention period, they are measured a last time using the same outcome measures as during the previous measuring moments.
Interventions
During a 4-week intervention, participants get 48 hours additional sensorimotor upper limb training. They will come 3 times per week to Leuven for a therapy session of two hours. During these therapy sessions, they receive one hour robot-based therapy and one hour transfer package training with a therapist. Additionally, they follow 6 times a week a 1-hour home program. This intervention can be distinguished from others since it integrates both motor and sensory function, with focus on sensory processing. It combines robot-based therapy, a transfer package to daily activities, and a home program.
Eligibility Criteria
You may qualify if:
- Written informed consent must be obtained prior to any screening procedures
- A first-ever unilateral, supra-tentorial stroke, as defined by WHO (rapidly developing clinical signs of focal (or global) disturbance of cerebral function, with symptoms lasting 24 hours or longer or leading to death, with no apparent cause other than vascular origin)
- ≥18 years old
- Being in the chronic phase after stroke, i.e. \> 6 months post stroke
- Motor impairment in the upper limb, defined as Fugl-Meyer score \>22 out of 66 to demonstrate moderate to full upper limb motor function (patients scoring \<23 out of 66 will not be able to comply with the KINARM protocol)
- Residual sensory upper limb impairment, defined as Tactile Discrimination Test score \<24 out of 25
- Impaired functionality, defined as Action Research Arm Test score \<52 out of 57
- Manageable spasticity for KINARM tasks
You may not qualify if:
- Having musculoskeletal and/or other neurological disorders impacting care or prognosis
- Having severe communication or cognitive deficits that interfere with the protocol
- Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the CIP
- Contraindications for robot-based therapy (e.g., uncontrolled epilepsy)
- Participation in another clinical investigation
- Having uncontrolled head movements (e.g. tremor), only relevant if participant is willing to receive the additional fNIRS assessments
- Having any contra-indications for MRI, only relevant if participant is willing to receive the additional MRI assessments:
- Pacemaker
- Implantable Cardioverter Defibrillator (ICD)
- Cochlear implant
- Internal Insulin-pump
- Deep brain stimulation
- Any other metal device in body
- Claustrophobia
- Having a history of a neuropsychiatric or neurologic disorder before the diagnosis of stroke (e.g., depression, traumatic brain injury)
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
Study Sites (1)
KU Leuven
Leuven, 3001, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
March 6, 2025
First Posted
March 11, 2025
Study Start
February 18, 2025
Primary Completion
October 2, 2025
Study Completion
October 2, 2025
Last Updated
March 19, 2026
Record last verified: 2026-03